Figure 2

MyPEAK-1 Multiple Measures June 2026

Multiple parameters of disease improved in a majority of MyPEAK-1 clinical trial participants following treatment with TN-201

Format

JPEG

Source

Tenaya Therapeutics, Inc.

Downloads